128 related articles for article (PubMed ID: 10025873)
21. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine.
Iigo M; Alexander DB; Xu J; Futakuchi M; Suzui M; Kozu T; Akasu T; Saito D; Kakizoe T; Yamauchi K; Abe F; Takase M; Sekine K; Tsuda H
Biometals; 2014 Oct; 27(5):1017-29. PubMed ID: 24867408
[TBL] [Abstract][Full Text] [Related]
23. Dietary bovine lactoferrin increases intestinal cell proliferation in neonatal piglets.
Reznikov EA; Comstock SS; Yi C; Contractor N; Donovan SM
J Nutr; 2014 Sep; 144(9):1401-8. PubMed ID: 25056692
[TBL] [Abstract][Full Text] [Related]
24. Effect of Bovine Lactoferrin Treatment Followed by Acute Stress on the IgA-Response in Small Intestine of BALB/c Mice.
Peña-Juárez MC; Campos-Rodríguez R; Godínez-Victoria M; Cruz-Hernández TR; Reyna-Garfias H; Barbosa-Cabrera RE; Drago-Serrano ME
Immunol Invest; 2016 Oct; 45(7):652-67. PubMed ID: 27611298
[TBL] [Abstract][Full Text] [Related]
25. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
Tanaka T; Kawabata K; Kohno H; Honjo S; Murakami M; Ota T; Tsuda H
Jpn J Cancer Res; 2000 Jan; 91(1):25-33. PubMed ID: 10744041
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
28. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
29. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
Song J; Medline A; Mason JB; Gallinger S; Kim YI
Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
[TBL] [Abstract][Full Text] [Related]
30. Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats.
Tamano S; Sekine K; Takase M; Yamauchi K; Iigo M; Tsuda H
Asian Pac J Cancer Prev; 2008; 9(2):313-6. PubMed ID: 18712982
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea.
Niho N; Mutoh M; Sakano K; Takahashi M; Hirano S; Nukaya H; Sugimura T; Wakabayashi K
Cancer Sci; 2006 Apr; 97(4):248-51. PubMed ID: 16630115
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells.
Kawasaki Y; Tazume S; Shimizu K; Matsuzawa H; Dosako S; Isoda H; Tsukiji M; Fujimura R; Muranaka Y; Isihida H
Biosci Biotechnol Biochem; 2000 Feb; 64(2):348-54. PubMed ID: 10737192
[TBL] [Abstract][Full Text] [Related]
35. Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection.
Wu J; Chen J; Wu W; Shi J; Zhong Y; van Tol EA; Tang Q; Cai W
Br J Nutr; 2014 Aug; 112(4):486-92. PubMed ID: 24830343
[TBL] [Abstract][Full Text] [Related]
36. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals.
Tsuda H; Sekine K; Takasuka N; Toriyama-Baba H; Iigo M
Biofactors; 2000; 12(1-4):83-8. PubMed ID: 11216510
[TBL] [Abstract][Full Text] [Related]
37. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse.
Paulsen JE; Elvsaas IK; Steffensen IL; Alexander J
Carcinogenesis; 1997 Oct; 18(10):1905-10. PubMed ID: 9363998
[TBL] [Abstract][Full Text] [Related]
38. Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis.
Kuhara T; Tanaka A; Yamauchi K; Iwatsuki K
Br J Nutr; 2014 May; 111(10):1801-10. PubMed ID: 24472388
[TBL] [Abstract][Full Text] [Related]
39. Reduction of intestinal polyp formation in min mice fed a high-fat diet with aloe vera gel extract.
Chihara T; Shimpo K; Beppu H; Tomatsu A; Kaneko T; Tanaka M; Yamada M; Abe F; Sonoda S
Asian Pac J Cancer Prev; 2013; 14(7):4435-40. PubMed ID: 23992016
[TBL] [Abstract][Full Text] [Related]
40. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]